Regulations for Drug Research - Amy Emerson & Michelle Weitz - Part 1 of 2

Clinical drug development requires adherence to strict regulatory frameworks to ensure patient safety and data integrity. Investigators in human clinical studies must operate within protocols that align with Good Clinical Practices (GCP) and relevant federal or international regulations. These standards ensure that trial data is credible and reproducible, which is essential for gaining eventual regulatory approval for new drug applications. Successful compliance involves identifying all key players, such as sponsors, site teams, and institutional review boards, and explicitly defining their responsibilities. Common regulatory pitfalls include deviations from written protocols, improper consent processes, and inadequate documentation of patient information or drug accountability. Rigorous monitoring and training are critical to mitigate these risks and maintain a high standard of research quality throughout the study.